Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate adjunctive therapy in adults with partial-onset seizures
CTR20210908Phase 3Completed
- Sponsor
- SK Life Science, Inc.
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cenobamate in epilepsy, sponsored by SK Life Science, Inc.. Started May 2021; status: completed.
02
Drugs
cenobamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20210908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210908.